Viking Therapeutics, Inc. - 8-K Filing

Viking Therapeutics raised $547.8M through equity offering (7.86M shares at $35/share) and debt issuance of $225M in convertible senior notes (Items: 1.01 Entry into a Material Definitive Agreement, 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $VKTX

Read the full article at SEC EDGAR

More Regulatory news